$35.20
-1.23-3.38%
At close: -
$36.16
0.962.73%
After Hours: Jul 18, 6:27 PM EDT
Comments
Loading...
Harmony Biosciences Hldgs Earnings Estimates, EPS & Revenue | NASDAQ:HRMY | Benzinga
Harmony Biosciences Hldgs reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 5
EPS Estimate
$0.723
Quarterly Revenue Estimate
$204.45M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$744.85M
Analyze the earnings history of Harmony Biosciences Hldgs using advanced sorting and filters.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
HRMY | Harmony Biosciences | $1.05 | $0.72 | — | — | $172.81M | $204.45M | — | — | 08/05/2025 | |
HRMY | Harmony Biosciences | $0.88 | $0.59 | $1.03 | 13.19% | $154.62M | $182.90M | $184.73M | 1.35% | 05/06/2025 | |
HRMY | Harmony Biosciences | $0.73 | $0.74 | $1.08 | 31.71% | $168.41M | $200.99M | $201.27M | 0.01% | 02/25/2025 | |
HRMY | Harmony Biosciences | $0.97 | $0.67 | $1.03 | 56.06% | $160.27M | $184.06M | $186.04M | 1.07% | 10/29/2024 | |
HRMY | Harmony Biosciences | $0.76 | -$0.06 | $1.05 | 1850.00% | $134.22M | $173.10M | $172.81M | 0.16% | 08/06/2024 | |
HRMY | Harmony Biosciences | $0.67 | $0.62 | $0.88 | 41.94% | $119.13M | $154.80M | $154.62M | -0.12% | 04/30/2024 | |
HRMY | Harmony Biosciences | $1.01 | $0.48 | $0.73 | 52.08% | $128.31M | $169.06M | $168.41M | -0.38% | 02/22/2024 | |
HRMY | Harmony Biosciences | $0.95 | $0.65 | $0.97 | 49.23% | $117.21M | $148.87M | $160.27M | 7.66% | 10/31/2023 | |
HRMY | Harmony Biosciences | $0.57 | $0.62 | $0.76 | 22.58% | $107.03M | $139.79M | $134.22M | -3.99% | 08/01/2023 | |
HRMY | Harmony Biosciences | $0.51 | $0.47 | $0.66 | 40.43% | $85.31M | $116.79M | $119.13M | 2.00% | 05/02/2023 | |
HRMY | Harmony Biosciences | $0.63 | $0.58 | $1.01 | 74.14% | $91.21M | $127.34M | $128.31M | 0.76% | 02/21/2023 | |
HRMY | Harmony Biosciences | $0.51 | $0.13 | $0.95 | 630.77% | $80.73M | $113.54M | $117.21M | 3.23% | 11/01/2022 | |
HRMY | Harmony Biosciences | $0.54 | $0.44 | $0.57 | 29.55% | $73.82M | $100.75M | $107.03M | 6.23% | 08/02/2022 | |
HRMY | Harmony Biosciences | $0.38 | $0.29 | $0.51 | 75.86% | $59.67M | $88.55M | $85.31M | -3.66% | 05/03/2022 | |
HRMY | Harmony Biosciences | $0.25 | $0.37 | $0.63 | 70.27% | $56.29M | $90.01M | $91.21M | 1.34% | 02/28/2022 | |
HRMY | Harmony Biosciences | -$0.14 | $0.28 | $0.51 | 82.14% | $45.61M | $79.85M | $80.73M | 1.10% | 11/09/2021 | |
HRMY | Harmony Biosciences | — | $0.18 | $0.54 | 200.00% | — | $68.77M | $73.82M | 7.34% | 08/10/2021 | |
HRMY | Harmony Biosciences | — | -$0.03 | $0.38 | 1366.67% | — | $57.07M | $59.67M | 4.56% | 05/11/2021 | |
HRMY | Harmony Biosciences | — | $0.09 | $0.25 | 177.78% | — | $51.85M | $56.29M | 8.56% | 03/25/2021 | |
HRMY | Harmony Biosciences | — | -$0.05 | -$0.14 | -180.00% | — | $40.07M | $45.61M | 13.82% | 11/12/2020 |
Harmony Biosciences Hldgs (HRMY) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-06 | $1.03 | $0.59 | 13.2 % |
| Q4 | 2025-02-25 | $1.08 | $0.74 | 31.7 % |
| Q3 | 2024-10-29 | $1.03 | $0.67 | 56.1 % |
| Q2 | 2024-08-06 | $1.05 | $-0.06 | 1850.0 % |
Harmony Biosciences Hldgs (HRMY) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-06 | $184.73M | $182.90M | 1.35 % |
| Q4 | 2025-02-25 | $201.27M | $200.99M | 0.01 % |
| Q3 | 2024-10-29 | $186.04M | $184.06M | 1.07 % |
| Q2 | 2024-08-06 | $172.81M | $173.10M | 0.16 % |
FAQ
When is Harmony Biosciences Hldgs (NASDAQ:HRMY) reporting earnings?
Harmony Biosciences Hldgs (HRMY) is scheduled to report earnings on August 5, 2025. The last reported earnings were for reported on May 6, 2025 for Q1.
What were the latest earnings per share (EPS) for Harmony Biosciences Hldgs (NASDAQ:HRMY)?
The Actual EPS was $1.03, which beat the estimate of $0.59.
What were Harmony Biosciences Hldgs’s (NASDAQ:HRMY) revenues?
The Actual Revenue was $184.7M, which beat the estimate of $182.9M.
Browse earnings estimates, EPS, and revenue on all stocks.
